One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice ...

Amgen just handed income investors another dividend raise, but a mountain of acquisition debt, crumbling legacy drugs, and a ...

Amgen Inc. (NASDAQ:AMGN) has sold its office campus in Deerfield, Illinois, for $151 million. The buyer is an entity tied to ...

Novartis just handed the entire Lp(a) drug class a failing grade, and Amgen is taking the worst of the punishment despite releasing promising trial results of its own on the very same morning.

Shares of Walt Disney and Amgen are trading lower Thursday afternoon, sending the Dow Jones Industrial Average into negative territory. Shares of Walt Disney and Amgen are contributing to the index's ...

The Trump administration has selected 10 companies, including AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), and GSK (GSK), for a new pilot program that tests a rebate model for drugs purchased under a ...

Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a critical divide for income-focused investors.

Amgen has shed light on its phase 2 lupus win, revealing that its monoclonal antibody daxdilimab was tied to a 6-point reduction in disease severity at the lower dose. | Amgen has shed light on its ...

Dazodalibep, acquired in Amgen’s big buyout of Horizon Therapeutics, succeeded in the first of two late-stage trials against ...

Amgen (AMGN) stock drops after a phase 3 trial failure for a heart drug from Novartis (NVS) and Ionis Pharma (IONS). BMO Capital Markets downgrades. Read more here.

Amgen stock bounded above its 50-day line Tuesday after publishing promising results for its experimental Sjogren's treatment ...

Amgen (AMGN) stock rises after Phase 3 trial win for dazodalibep, an experimental therapy for an autoimmune condition called Sjögren's disease. Read more here.